These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 38298707)
1. Current state of immune checkpoints therapy for glioblastoma. Wang H; Yang J; Li X; Zhao H Heliyon; 2024 Jan; 10(2):e24729. PubMed ID: 38298707 [TBL] [Abstract][Full Text] [Related]
2. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds. Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932 [TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint in Glioblastoma: Promising and Challenging. Huang J; Liu F; Liu Z; Tang H; Wu H; Gong Q; Chen J Front Pharmacol; 2017; 8():242. PubMed ID: 28536525 [TBL] [Abstract][Full Text] [Related]
4. Combination immunotherapy strategies for glioblastoma. Chan HY; Choi J; Jackson C; Lim M J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705 [TBL] [Abstract][Full Text] [Related]
5. Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence. Kreatsoulas D; Bolyard C; Wu BX; Cam H; Giglio P; Li Z J Hematol Oncol; 2022 Jun; 15(1):80. PubMed ID: 35690784 [TBL] [Abstract][Full Text] [Related]
6. Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma. Zhang N; Wei L; Ye M; Kang C; You H Front Immunol; 2020; 11():592612. PubMed ID: 33329578 [TBL] [Abstract][Full Text] [Related]
8. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements. Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718 [TBL] [Abstract][Full Text] [Related]
9. Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma. Shen S; Chen L; Liu J; Yang L; Zhang M; Wang L; Zhang R; Uemura Y; Wu Q; Yu X; Liu T Cancer Biol Med; 2020 Aug; 17(3):555-568. PubMed ID: 32944390 [TBL] [Abstract][Full Text] [Related]
10. TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma. Raphael I; Kumar R; McCarl LH; Shoger K; Wang L; Sandlesh P; Sneiderman CT; Allen J; Zhai S; Campagna ML; Foster A; Bruno TC; Agnihotri S; Hu B; Castro BA; Lieberman FS; Broniscer A; Diaz AA; Amankulor NM; Rajasundaram D; Pollack IF; Kohanbash G Front Immunol; 2021; 12():637146. PubMed ID: 34025646 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors. Medikonda R; Pant A; Lim M Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382 [TBL] [Abstract][Full Text] [Related]